Biblio

Found 12 results
Filters: Keyword is Oligonucleotide Array Sequence Analysis  [Clear All Filters]
2008
Junk DJ, Vrba L, Watts GS, Oshiro MM, Martinez JD, Futscher BW.  2008.  Different mutant/wild-type p53 combinations cause a spectrum of increased invasive potential in nonmalignant immortalized human mammary epithelial cells.. Neoplasia. 10(5):450-61.
2007
Goulet A-C, Watts G, Lord JL, Nelson MA.  2007.  Profiling of selenomethionine responsive genes in colon cancer by microarray analysis.. Cancer Biol Ther. 6(4):494-503.
2006
Li H, Watts GS, Oshiro MM, Futscher BW, Domann FE.  2006.  AP-2alpha and AP-2gamma are transcriptional targets of p53 in human breast carcinoma cells.. Oncogene. 25(39):5405-15.
Ignatenko NA, Yerushalmi HF, Watts GS, Futscher BW, Stringer DE, Marton LJ, Gerner EW.  2006.  Pharmacogenomics of the polyamine analog 3,8,13,18-tetraaza-10,11-[(E)-1,2-cyclopropyl]eicosane tetrahydrochloride, CGC-11093, in the colon adenocarcinoma cell line HCT1161.. Technol Cancer Res Treat. 5(6):553-64.
2004
Watts GS, Oshiro MM, Junk DJ, Wozniak RJ, Watterson S, Domann FE, Futscher BW.  2004.  The acetyltransferase p300/CBP-associated factor is a p53 target gene in breast tumor cells.. Neoplasia. 6(3):187-94.
Ignatenko NA, Zhang H, Watts GS, Skovan BA, Stringer DE, Gerner EW.  2004.  The chemopreventive agent alpha-difluoromethylornithine blocks Ki-ras-dependent tumor formation and specific gene expression in Caco-2 cells.. Mol Carcinog. 39(4):221-33.
Shippy R, Sendera TJ, Lockner R, Palaniappan C, Kaysser-Kranich T, Watts G, Alsobrook J.  2004.  Performance evaluation of commercial short-oligonucleotide microarrays and the impact of noise in making cross-platform correlations.. BMC Genomics. 5:61.
2003
Zheng XHui, Watts GS, Vaught S, A Gandolfi J.  2003.  Low-level arsenite induced gene expression in HEK293 cells.. Toxicology. 187(1):39-48.
Oshiro MM, Watts GS, Wozniak RJ, Junk DJ, Munoz-Rodriguez JL, Domann FE, Futscher BW.  2003.  Mutant p53 and aberrant cytosine methylation cooperate to silence gene expression.. Oncogene. 22(23):3624-34.
2002
Crowley-Weber CL, Payne CM, Gleason-Guzman M, Watts GS, Futscher B, Waltmire CN, Crowley C, Dvorakova K, Bernstein C, Craven M et al..  2002.  Development and molecular characterization of HCT-116 cell lines resistant to the tumor promoter and multiple stress-inducer, deoxycholate.. Carcinogenesis. 23(12):2063-80.
2001
Watts GS, Futscher BW, Isett R, Gleason-Guzman M, Kunkel MW, Salmon SE.  2001.  cDNA microarray analysis of multidrug resistance: doxorubicin selection produces multiple defects in apoptosis signaling pathways.. J Pharmacol Exp Ther. 299(2):434-41.
Calaluce R, Kunkel MW, Watts GS, Schmelz M, Hao J, Barrera J, Gleason-Guzman M, Isett R, Fitchmun M, Bowden GT et al..  2001.  Laminin-5-mediated gene expression in human prostate carcinoma cells.. Mol Carcinog. 30(2):119-29.